Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated other comprehensive income	Accumulated deficit	Total
Balance at Beginning of period at Dec. 31, 2021	$ 15	$ 250,064	$ (52)	$ (229,929)	$ 20,098
Balance at Beginning of period (in shares) at Dec. 31, 2021	14,529,577
Vesting of common stock previously subject to repurchase (in shares)	29
Vesting of restricted stock units and exercise of stock options		19			19
Vesting of restricted stock units and exercise of stock options (in shares)	44,346
Issuance of common stock under the employee stock purchase plan		50			50
Issuance of common stock under the employee stock purchase plan (in shares)	4,523
Shares withheld for employee taxes		(157)			(157)
Shares withheld for employee taxes (in shares)	(13,448)
Foreign currency translation adjustment			202		202
Stock-based compensation expense		3,989			3,989
Sale of common stock, net of underwriting discounts, commissions and offering costs	$ 4	34,396			34,400
Sale of common stock, net of underwriting discounts, commissions and offering costs (in shares)	4,600,000
Net loss				(44,296)	(44,296)
Balance at Ending period at Dec. 31, 2022	$ 19	288,361	150	(274,225)	14,305
Balance at Ending period (in shares) at Dec. 31, 2022	19,165,027
Vesting of restricted stock units and exercise of stock options		127			127
Vesting of restricted stock units and exercise of stock options (in shares)	126,987
Issuance of common stock under the employee stock purchase plan		88			88
Issuance of common stock under the employee stock purchase plan (in shares)	10,602
Shares withheld for employee taxes		(289)			(289)
Shares withheld for employee taxes (in shares)	(27,131)
Foreign currency translation adjustment			(59)		(59)
Stock-based compensation expense		5,032			5,032
Sale of common stock, net of underwriting discounts, commissions and offering costs	$ 5	46,336			46,341
Sale of common stock, net of underwriting discounts, commissions and offering costs (in shares)	5,219,190
Net loss				(46,664)	(46,664)
Balance at Ending period at Dec. 31, 2023	$ 24	339,655	91	(320,889)	18,881
Balance at Ending period (in shares) at Dec. 31, 2023	24,494,675
Vesting of restricted stock units and exercise of stock options	$ 1	225			226
Vesting of restricted stock units and exercise of stock options (in shares)	229,606
Issuance of common stock under the employee stock purchase plan		281			281
Issuance of common stock under the employee stock purchase plan (in shares)	58,994
Shares withheld for employee taxes		(369)			(369)
Shares withheld for employee taxes (in shares)	(57,563)
Foreign currency translation adjustment			(1)		(1)
Stock-based compensation expense		4,362			4,362
Sale of common stock and pre-funded warrants, net of underwriting discounts, commissions and offering costs	$ 14	42,905			42,919
Sale of common stock and pre-funded warrants, net of underwriting discounts, commissions and offering costs (in shares)	14,670,000
Net loss				(37,841)	(37,841)
Balance at Ending period at Dec. 31, 2024	$ 39	$ 387,059	$ 90	$ (358,730)	$ 28,458
Balance at Ending period (in shares) at Dec. 31, 2024	39,395,712